Literature DB >> 30222702

Being "False Positive": An "Inconvenience"? Debates and Questions Regarding the Notion of Vaccine-Induced Seropositivity (VISP) in the Recruitment of Healthy Volunteers for a Preventive Anti-HIV Vaccine Trial.

Mathilde Couderc.   

Abstract

This article considers a stage in the clinical trial process seldom documented in social sciences: recruitment of healthy volunteers for an HIV preventive vaccine trial through a media campaign. It analyzes one of the consequences of participating in such a clinical trial: the development of vaccine-induced seropositivity (VISP) and how this biomedical notion is mobilized both in recruitment procedures' normative discourses and from the volunteers' points of view, and its consequences on their decision to participate. The interpretations of VISP by volunteers depend on several factors: socialization, itinerary into the recruitment procedure, sexuality, etc., and generates diverse feelings such as indifference, doubt, or even fear. Fear of VISP represents the principal refusal reason for those who interrupted their participating step, just before inclusion stage. Addressing VISP phenomenon is important because it represents a major challenge for the information and the communication procedures for the next anti-HIV prophylactic trials recruitment campaigns.

Mesh:

Substances:

Year:  2018        PMID: 30222702     DOI: 10.1097/QAI.0000000000001814

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  2 in total

1.  "An Extra Variable to Consider"-Vaccine-Induced Seropositivity and Adolescent HIV Vaccine Clinical Trials.

Authors:  Omolayo Fatola; Amy Corneli; Brian Perry; Emily Hanlen-Rosado; Adora Nsonwu; Evangelia P Constantine; Amelia B Thompson
Journal:  J Pediatric Infect Dis Soc       Date:  2022-05-30       Impact factor: 5.235

2.  Poststudy Point-of-Care Oral Fluid Testing in Human Immunodeficiency Virus-1 Vaccinees.

Authors:  Karina Oganezova; Elvin J Fontana-Martinez; Jon A Gothing; Alisha Pandit; Esther Kwara; Katherine Yanosick; Joan Dragavon; Erin A Goecker; Janine Maenza; Nicole Espy; Frank Tomaka; Ludo Lavreys; Mary Allen; Patricia D'Souza; John Hural; Robert W Coombs; Raphael Dolin; Michael S Seaman; Stephen R Walsh; Lindsey R Baden
Journal:  Open Forum Infect Dis       Date:  2020-12-15       Impact factor: 3.835

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.